Results 231 to 240 of about 14,659,030 (367)
AI-ming backwards: Vanishing archaeological landscapes in Mesopotamia and automatic detection of sites on CORONA imagery. [PDF]
Pistola A+3 more
europepmc +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou+5 more
wiley +1 more source
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban+12 more
wiley +1 more source
Computer-aided Nodule Detection in the Lung Apices in Head and Neck Computed Tomography Angiography: An Unexpected Opportunity. [PDF]
Kass TP+4 more
europepmc +1 more source
Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun+5 more
wiley +1 more source
Semi-parametric validation of genomic predictions and polygenic risk scores with the Blupf90 software suite. [PDF]
Bermann M+3 more
europepmc +1 more source
DREAM - an approach to designing large scale, concurrent software systems [PDF]
Jack C. Wileden
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source
Multi release software reliability modelling incorporating fault generation in detection process and fault dependency with change point in correction process. [PDF]
Pradhan SK, Kumar A, Kumar V.
europepmc +1 more source